S. Cholerton

2.6k total citations
40 papers, 2.1k citations indexed

About

S. Cholerton is a scholar working on Pharmacology, Molecular Biology and Nutrition and Dietetics. According to data from OpenAlex, S. Cholerton has authored 40 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 13 papers in Molecular Biology and 7 papers in Nutrition and Dietetics. Recurrent topics in S. Cholerton's work include Pharmacogenetics and Drug Metabolism (17 papers), Glutathione Transferases and Polymorphisms (7 papers) and Vitamin K Research Studies (6 papers). S. Cholerton is often cited by papers focused on Pharmacogenetics and Drug Metabolism (17 papers), Glutathione Transferases and Polymorphisms (7 papers) and Vitamin K Research Studies (6 papers). S. Cholerton collaborates with scholars based in United Kingdom, Türkiye and Jordan. S. Cholerton's co-authors include Jeffrey R. Idle, Ann K. Daly, Melissa J. Armstrong, AM Breckenridge, D. Nicholas Bateman, BP Haynes, W. Larry Gregory, Pedro M. Fernández‐Salguero, Arja Rautio and Olavi Pelkonen and has published in prestigious journals such as The Lancet, Environmental Health Perspectives and British Journal of Cancer.

In The Last Decade

S. Cholerton

40 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Cholerton United Kingdom 24 937 716 370 239 198 40 2.1k
Danièle Lucas France 31 974 1.0× 819 1.1× 327 0.9× 203 0.8× 276 1.4× 50 2.7k
G. M. Pacifici Italy 29 836 0.9× 847 1.2× 447 1.2× 150 0.6× 250 1.3× 105 2.5k
Donald S. Davies United Kingdom 31 1.3k 1.3× 923 1.3× 709 1.9× 359 1.5× 198 1.0× 92 3.0k
Julio Benítez Spain 27 767 0.8× 464 0.6× 399 1.1× 107 0.4× 151 0.8× 52 1.9k
Véronique Descatoire France 31 1.2k 1.3× 686 1.0× 614 1.7× 180 0.8× 162 0.8× 56 2.8k
Alain Berson France 36 1.3k 1.4× 1.3k 1.8× 456 1.2× 109 0.5× 328 1.7× 59 3.9k
George B. Corcoran United States 27 1.4k 1.5× 843 1.2× 596 1.6× 203 0.8× 212 1.1× 63 3.2k
William A. Garland United States 29 579 0.6× 1.4k 1.9× 231 0.6× 179 0.7× 171 0.9× 101 2.9k
Jean‐Charles Gautier France 27 1.2k 1.3× 852 1.2× 646 1.7× 269 1.1× 128 0.6× 60 2.8k
David Y. Cooper United States 22 1.4k 1.5× 1.1k 1.5× 375 1.0× 153 0.6× 180 0.9× 67 2.8k

Countries citing papers authored by S. Cholerton

Since Specialization
Citations

This map shows the geographic impact of S. Cholerton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Cholerton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Cholerton more than expected).

Fields of papers citing papers by S. Cholerton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Cholerton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Cholerton. The network helps show where S. Cholerton may publish in the future.

Co-authorship network of co-authors of S. Cholerton

This figure shows the co-authorship network connecting the top 25 collaborators of S. Cholerton. A scholar is included among the top collaborators of S. Cholerton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Cholerton. S. Cholerton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Price, L, Michael J. Tilby, Dianne Ford, et al.. (2005). Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancer. British Journal of Cancer. 92(9). 1626–1635. 11 indexed citations
2.
Cholerton, S., et al.. (2004). Genetic polymorphism of manganese superoxide dismutase (MnSOD) and breast cancer susceptibility. Cell Biochemistry and Function. 23(1). 73–76. 34 indexed citations
3.
Daly, Ann K., et al.. (2003). Analysis of Cytochrome P450 Polymorphisms. Humana Press eBooks. 107. 405–422. 20 indexed citations
4.
Kocabaş, Neslihan Aygün, A.E. Karakaya, S. Cholerton, & Semra Şardaş. (2001). Catechol- O -methyltransferase (COMT) genetic polymorphism in a Turkish population. Archives of Toxicology. 75(7). 407–409. 6 indexed citations
5.
Irshaid, Yacoub M., Cathrine Broberg Vågbø, Anders Brunsvik, et al.. (1998). Variability of coumarin 7- and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6. European Journal of Clinical Pharmacology. 54(5). 437–441. 37 indexed citations
6.
Singleton, Andrew, et al.. (1998). Lack of association between the dopamine D2 receptor gene allele DRD2*A1 and cigarette smoking in a United Kingdom population. Pharmacogenetics. 8(2). 125–128. 60 indexed citations
7.
Zahlsen, K., et al.. (1997). A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin. Food and Chemical Toxicology. 35(9). 903–907. 83 indexed citations
8.
Idle, Jeffrey R., et al.. (1997). CYP2D6 genotype and smoking behaviour in cigarette smokers. Pharmacogenetics. 7(5). 411–414. 29 indexed citations
9.
Ellis, Janice, et al.. (1996). Automated gas chromatographic assay for amlodipine in plasma and gingival crevicular fluid. Journal of Chromatography B Biomedical Sciences and Applications. 678(2). 360–364. 54 indexed citations
10.
Şardaş, Semra, et al.. (1996). Trimethylamine N-oxidation in Turkish women with bacterial vaginosis. Pharmacogenetics. 6(5). 459–463. 4 indexed citations
11.
Cholerton, S., et al.. (1996). CYP2D6 genotypes in cigarette smokers and nontobacco users. Pharmacogenetics. 6(3). 261–263. 31 indexed citations
12.
Walker, Dianne, Jean-Pierre Flinois, Alan V. Boddy, et al.. (1994). Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide. Biochemical Pharmacology. 47(7). 1157–1163. 105 indexed citations
13.
Cholerton, S., et al.. (1994). Debrisoquine 4-hydroxylation (CYP2D6) polymorphism in Jordanians. Pharmacogenetics. 4(3). 159–161. 10 indexed citations
14.
Daly, Ann K., S. Cholerton, Melissa J. Armstrong, & Jeffrey R. Idle. (1994). Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility.. Environmental Health Perspectives. 102(suppl 9). 55–61. 78 indexed citations
15.
Daly, Ann K., S. Cholerton, W. Larry Gregory, & Jeffrey R. Idle. (1993). Metabolic polymorphisms. Pharmacology & Therapeutics. 57(2-3). 129–160. 138 indexed citations
16.
Cholerton, S., Ann K. Daly, & Jeffrey R. Idle. (1992). The role of individual human cytochrpmes P450 in drug metabolism and clinical response. Trends in Pharmacological Sciences. 13(12). 434–439. 211 indexed citations
17.
Cholerton, S., et al.. (1992). Comparison of a novel thin-layer chromatographic—fluorescence detection method with a spectrofluorometric method for the determination of 7-hydroxycoumarin in human urine. Journal of Chromatography B Biomedical Sciences and Applications. 575(2). 325–330. 71 indexed citations
18.
Cholerton, S., R. Ayesh, Jeffrey R. Idle, & Richard L. Smith. (1988). The preeminence of nicotine n oxidation and its diminution after carbimazole administration. British Journal of Clinical Pharmacology. 26(5). 652–653. 7 indexed citations
19.
Cholerton, S., et al.. (1988). An investigation of the pharmacological response to vitamin K1 in the rabbit. British Journal of Pharmacology. 94(4). 1077–1084. 4 indexed citations
20.
Haynes, BP, et al.. (1986). Enantiomers of warfarin and vitamin K1 metabolism.. British Journal of Clinical Pharmacology. 22(6). 729–732. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danièle Lucas Breakdown of academic impact, for papers by G. M. Pacifici Breakdown of academic impact, for papers by Donald S. Davies Breakdown of academic impact, for papers by Julio Benítez Breakdown of academic impact, for papers by Véronique Descatoire Breakdown of academic impact, for papers by Alain Berson Breakdown of academic impact, for papers by George B. Corcoran Breakdown of academic impact, for papers by William A. Garland Breakdown of academic impact, for papers by Jean‐Charles Gautier Breakdown of academic impact, for papers by David Y. Cooper
Rankless by CCL
2026